Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
| Autor(en): | Semiglazov, Vladimir Semiglazov, Vladislav Dashyan, G.A. Ziltsova, E.K. Ivanov, Vadim T. Aa, Bozhok Melnikova, Olga Rm, Paltuev Kletzel, A. Berstein, Lev M. |
Stichwörter: | Medicine; Neoadjuvant therapy; Chemotherapy; Internal medicine; Anastrozole; Aromatase; Oncology; Breast cancer; Exemestane; Cancer | Erscheinungsdatum: | 2007 | Volumen: | 110 | Ausgabe: | 2 | Startseite: | 244 | Seitenende: | 254 | DOI: | https://doi.org/10.1002/cncr.22789 |
Zur Langanzeige
